Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62070327 | chr16:89583610 | C/T | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs62076865 | chr17:36948071 | A/G | 6.6E-8 | 178 | 25.17 | 36.53 | 24.53 | KM Plot |
PCPG | rs62080680 | chr17:53779133 | C/T | 8.79E-5 | 176 | 25.87 | 20.13 | 17.27 | KM Plot |
PCPG | rs62085145 | chr17:74700126 | G/A | 0.000168 | 177 | 25.97 | 19.57 | 13.5 | KM Plot |
PCPG | rs62085155 | chr17:74705892 | A/C | 0.00016 | 175 | 26.27 | 14.35 | 13.5 | KM Plot |
PCPG | rs62110407 | chr19:52785755 | G/A | 0.00035 | 173 | 25.53 | 28.3 | 18.2 | KM Plot |
PCPG | rs62137778 | chr19:19682541 | A/G | 0.000314 | 178 | 25.77 | 26.05 | 23.48 | KM Plot |
PCPG | rs62186369 | chr2:242191140 | A/G | 5.62E-5 | 173 | 24.17 | 32.92 | 9.13 | KM Plot |
PCPG | rs62191740 | chr2:242515516 | C/T | 5.72E-11 | 176 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs62192961 | chr2:242519719 | G/A | 4.22E-5 | 177 | 25.87 | 25.67 | 20.2 | KM Plot |
PCPG | rs62192963 | chr2:242520800 | G/A | 4.19E-11 | 178 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs62192999 | chr2:242534467 | C/T | 4.16E-5 | 177 | 25.87 | 26.47 | 20.28 | KM Plot |
PCPG | rs62193000 | chr2:242534709 | C/T | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs62193001 | chr2:242534748 | G/A | 4.39E-5 | 177 | 25.87 | 29.57 | 19.75 | KM Plot |
PCPG | rs62193002 | chr2:242534781 | A/G | 4.39E-5 | 177 | 25.87 | 29.57 | 19.75 | KM Plot |